Evaluation of recombinant invasive, non-pathogenic eschericia coli as a vaccine vector against the intracellular pathogen, Brucella

Journal of Immune Based Therapies and Vaccines

Volumn 7, Issue , 2009, Pages

  Harms, Jerome S ^a   Durward, Marina A ^a   Magnani, Diogo M ^a   Splitter, Gary A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BRUCELLA VACCINE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 12; INVASIN; LISTERIOLYSIN O; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BAGG ALBINO MOUSE; BRUCELLA; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE VECTOR; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNE RESPONSE GENE; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PHAGOCYTE; TH1 CELL; YERSINIA PSEUDOTUBERCULOSIS;

EID: 61349162436     PISSN: None     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-7-1     Document Type: Article

References (80)

1. Ko J Splitter GA Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans Clin Microbiol Rev 2003, 16(1):65-78. 145300 12525425
2. Godfroid J Cloeckaert A Liautard JP Kohler S Fretin D Walravens K Garin-Bastuji B Letesson JJ From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis Vet Res 2005, 36(3):313-326. 15845228
3. Pappas G Akritidis N Bosilkovski M Tsianos E Brucellosis N Engl J Med 2005, 352(22):2325-2336. 15930423
4. Sarinas PS Chitkara RK Brucellosis Semin Respir Infect 2003, 18(3):168-182. 14505279
5. Sauret JM Vilissova N Human brucellosis J Am Board Fam Pract 2002, 15(5):401-406. 12350062
6. Bossi P Guihot A Bricaire F [Emerging or re-emerging infections that can be used for bioterrorism] Presse Med 2005, 34(2 Pt 2):149-155. 15687965
7. Han MH Zunt JR Bioterrorism and the nervous system Curr Neurol Neurosci Rep 2003, 3(6):476-482. 14565901
8. Horn JK Bacterial agents used for bioterrorism Surg Infect (Larchmt) 2003, 4(3):281-287. 14588163
9. Yagupsky P Baron EJ Laboratory exposures to brucellae and implications for bioterrorism Emerg Infect Dis 2005, 11(8):1180-1185. 16102304
10. Baldwin CL Goenka R Host immune responses to the intracellular bacteria Brucella: Does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol 2006, 26(5):407-442. 17341186
11. Rajashekara G Eskra L Mathison A Petersen E Yu Q Harms J Splitter G Brucella: Functional genomics and host-pathogen interactions Anim Health Res Rev 2006, 7(1-2):1-11. 17389050
12. Araj GF Human brucellosis: A classical infectious disease with persistent diagnostic challenges Clin Lab Sci 1999, 12(4):207-212. 10558306
13. Pappas G Papadimitriou P Challenges in Brucella bacteraemia Int J Antimicrob Agents 2007, 30(Suppl 1):S29-31. 17706402
14. Ashford DA di Pietra J Lingappa J Woods C Noll H Neville B Weyant R Bragg SL Spiegel RA Tappero J et al Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51 Vaccine 2004, 22(25-26):3435-3439. 15308369
15. Bardenstein S Mandelboim M Ficht TA Baum M Banai M Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene J Clin Microbiol 2002, 40(4):1475-1480. 140367 11923376
16. Blasco JM Diaz R Brucella melitensis Rev-1 vaccine as a cause of human brucellosis Lancet 1993, 342(8874):805. 8103891
17. Pivnick H Worton H Smith DL Barnum D Infection of veterinarians in Ontario by Brucella abortus strain 19 Can J Public Health 1966, 57(5):225-231. 4956571
18. Montaraz JA Winter AJ Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice Infect Immun 1986, 53(2):245-251. 260865 3089933
19. Oliveira SC Splitter GA CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice Eur J Immunol 1995, 25(9):2551-2557. 7589125
20. Baloglu S Toth TE Schurig GG Sriranganathan N Boyle SM Humoral immune response of BALB/c mice to a vaccinia virus recombinant expressing Brucella abortus GroEL does not correlate with protection against a B. abortus challenge Vet Microbiol 2000, 76(2):193-199. 10946149
21. Cassataro J Velikovsky CA de la Barrera S Estein SM Bruno L Bowden R Pasquevich KA Fossati CA Giambartolomei GH A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response Infect Immun 2005, 73(10):6537-6546. 1230944 16177328
22. Delpino MV Estein SM Fossati CA Baldi PC Cassataro J Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice Vaccine 2007, 25(37-38):6721-6729. 17686554
23. Golding B Scott DE Scharf O Huang LY Zaitseva M Lapham C Eller N Golding H Immunity and protection against Brucella abortus Microbes Infect 2001, 3(1):43-48. 11226853
24. Araya LN Elzer PH Rowe GE Enright FM Winter AJ Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus J Immunol 1989, 143(10):3330-3337. 2509555
25. Baloglu S Boyle SM Vemulapalli R Sriranganathan N Schurig GG Toth TE Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein Vet Microbiol 2005. 15941627
26. Inoue S Golding B Scott D Programming of CTL with heat-killed Brucella abortus and antigen allows soluble antigen alone to generate effective secondary CTL Vaccine 2005, 23(14):1730-1738. 15705479
27. Yingst S Hoover DL T cell immunity to brucellosis Crit Rev Microbiol 2003, 29(4):313-331. 14636042
28. He Y Vemulapalli R Zeytun A Schurig GG Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51 Infect Immun 2001, 69(9):5502-5508. 98663 11500423
29. Oliveira SC Harms JS Rech EL Rodarte RS Bocca AL Goes AM Splitter GA The role of T cell subsets and cytokines in the regulation of intracellular bacterial infection Braz J Med Biol Res 1998, 31(1):77-84. 9686182
30. Yu DH Li M Hu XD Cai H A combined DNA vaccine enhances protective immunity against Mycobacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector Vaccine 2007, 25(37-38):6744-6754. 17681650
31. Critchley RJ Jezzard S Radford KJ Goussard S Lemoine NR Grillot-Courvalin C Vassaux G Potential therapeutic applications of recombinant, invasive E. coli Gene Ther 2004, 11(15):1224-1233. 15141160
32. Buhler OT Wiedig CA Schmid Y Grassl GA Bohn E Autenrieth IB The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses Infect Immun 2006, 74(7):4322-4329. 1489713 16790806
33. Provoda CJ Lee KD Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules Adv Drug Deliv Rev 2000, 41(2):209-221. 10699316
34. Hu PQ Tuma-Warrino RJ Bryan MA Mitchell KG Higgins DE Watkins SC Salter RD Escherichia coli expressing recombinant antigen and listeriolysin O stimulate class I-restricted CD8+ T cells following uptake by human APC J Immunol 2004, 172(3):1595-1601. 14734740
35. Higgins DE Shastri N Portnoy DA Delivery of protein to the cytosol of macrophages using Escherichia coli K-12 Mol Microbiol 1999, 31(6):1631-1641. 10209738
36. Castagliuolo I Beggiao E Brun P Barzon L Goussard S Manganelli R Grillot-Courvalin C Palu G Engineered E. coli delivers therapeutic genes to the colonic mucosa Gene Ther 2005, 12(13):1070-1078. 15815705
37. Courvalin P Goussard S Grillot-Courvalin C Gene transfer from bacteria to mammalian cells C R Acad Sci III 1995, 318(12):1207-1212. 8745635
38. Critchley-Thorne RJ Stagg AJ Vassaux G Recombinant Escherichia coli expressing invasin targets the Peyer's patches: The basis for a bacterial formulation for oral vaccination Mol Ther 2006, 14(2):183-191. 16581299
39. Grillot-Courvalin C Goussard S Courvalin P Bacteria as gene delivery vectors for mammalian cells Curr Opin Biotechnol 1999, 10(5):477-481. 10508638
40. Grillot-Courvalin C Goussard S Courvalin P Wild-type intracellular bacteria deliver DNA into mammalian cells Cell Microbiol 2002, 4(3):177-186. 11906454
41. Grillot-Courvalin C Goussard S Huetz F Ojcius DM Courvalin P Functional gene transfer from intracellular bacteria to mammalian cells Nat Biotechnol 1998, 16(9):862-866. 9743121
42. Laner A Goussard S Ramalho AS Schwarz T Amaral MD Courvalin P Schindelhauer D Grillot-Courvalin C Bacterial transfer of large functional genomic DNA into human cells Gene Ther 2005, 12(21):1559-1572. 15973438
43. Radford KJ Higgins DE Pasquini S Cheadle EJ Carta L Jackson AM Lemoine NR Vassaux G A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: Application to cancer immunotherapy Gene Ther 2002, 9(21):1455-1463. 12378408
44. Radford KJ Jackson AM Wang JH Vassaux G Lemoine NR Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cells Int J Cancer 2003, 105(6):811-819. 12767067
45. Harms JS Eakle KA Kuo LS Bremel RD Splitter GA Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells Genet Vaccines Ther 2004, 2(1):11. 516020 15327692
46. Eskra L Canavessi A Carey M Splitter G Brucella abortus genes identified following constitutive growth and macrophage infection Infect Immun 2001, 69(12):7736-7742. 98869 11705955
47. Dricot A Rual JF Lamesch P Bertin N Dupuy D Hao T Lambert C Hallez R Delroisse JM Vandenhaute J et al Generation of the Brucella melitensis ORFeome version 1.1 Genome Res 2004, 14(10B):2201-2206. 528937 15489343
48. Fugier E Pappas G Gorvel JP Virulence factors in brucellosis: implications for aetiopathogenesis and treatment Expert Rev Mol Med 2007, 9(35):1-10. 18088444
49. Schmid D Pypaert M Munz C Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes Immunity 2007, 26(1):79-92. 1805710 17182262
50. Tosi MF Innate immune responses to infection J Allergy Clin Immunol 2005, 116(2):241-249. quiz 250 16083775
51. Nitcheu-Tefit J Dai MS Critchley-Thorne RJ Ramirez-Jimenez F Xu M Conchon S Ferry N Stauss HJ Vassaux G Listeriolysin O expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo J Immunol 2007, 179(3):1532-1541. 17641019
52. Gherardi MM Ramirez JC Esteban M Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: Suppressive effects of IL-12 boost are mediated by nitric oxide J Virol 2000, 74(14):6278-6286. 112133 10864637
53. Trinchieri G Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat Rev Immunol 2003, 3(2):133-146. 12563297
54. Zhang J He S Jiang H Yang T Cong H Zhou H Gu Q Li Y Zhao Q Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice Parasitol Res 2007, 101(2):331-338. 17265053
55. Boyaka PN Tafaro A Fischer R Fujihashi K Jirillo E McGhee JR Therapeutic manipulation of the immune system: Enhancement of innate and adaptive mucosal immunity Curr Pharm Des 2003, 9(24):1965-1972. 12871182
56. Gherardi MM Ramirez JC Esteban M Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens Histol Histopathol 2001, 16(2):655-667. 11332721
57. Zuckermann FA Martin S Husmann RJ Brandt J Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine Adv Vet Med 1999, 41:447-461. 9890035
58. Huang H Park CK Ryu JY Chang EJ Lee Y Kang SS Kim HH Expression profiling of lipopolysaccharide target genes in RAW264.7 cells by oligonucleotide microarray analyses Arch Pharm Res 2006, 29(10):890-897. 17121185
59. Hashimoto S Morohoshi K Suzuki T Matsushima K Lipopolysaccharide-inducible gene expression profile in human monocytes Scand J Infect Dis 2003, 35(9):619-627. 14620145
60. Reche PA Glutting JP Reinherz EL Prediction of MHC class I binding peptides using profile motifs Hum Immunol 2002, 63(9):701-709. 12175724
61. Billard E Dornand J Gross A Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells Infect Immun 2007, 75(12):5916-5923. 2168365 17938225
62. Giambartolomei GH Zwerdling A Cassataro J Bruno L Fossati CA Philipp MT Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus J Immunol 2004, 173(7):4635-4642. 15383598
63. Vemulapalli R He Y Boyle SM Sriranganathan N Schurig GG Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses Infect Immun 2000, 68(6):3290-3296. 97584 10816476
64. Rafiei A Ardestani SK Kariminia A Keyhani A Mohraz M Amirkhani A Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease J Infect 2006, 53(5):315-324. 16488475
65. Giambartolomei GH Delpino MV Cahanovich ME Wallach JC Baldi PC Velikovsky CA Fossati CA Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis J Infect Dis 2002, 186(2):252-259. 12134263
66. Larsen MD Griesenbach U Goussard S Gruenert DC Geddes DM Scheule RK Cheng SH Courvalin P Grillot-Courvalin C Alton EW Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli Gene Ther 2008, 15(6):434-442. 18317498
67. Brun P Zumbo A Castagliuolo I Delogu G Manfrin F Sali M Fadda G Grillot-Courvalin C Palu G Manganelli R Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli Vaccine 2008, 26(16):1934-1941. 18342411
68. Loessner H Weiss S Bacteria-mediated DNA transfer in gene therapy and vaccination Expert Opin Biol Ther 2004, 4(2):157-168. 14998775
69. Simon BE Leong JA Gene transfer to fish cells by attenuated invasive Escherichia coli Mar Biotechnol (NY) 2002, 4(3):303-309. 14961263
70. Weiss S Krusch S Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells Biol Chem 2001, 382(4):533-541. 11405218
71. Kohler S Porte F Jubier-Maurin V Ouahrani-Bettache S Teyssier J Liautard JP The intramacrophagic environment of Brucella suis and bacterial response Vet Microbiol 2002, 90(1-4):299-309. 12414150
72. Billard E Cazevieille C Dornand J Gross A High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis Infect Immun 2005, 73(12):8418-8424. 1307067 16299342
73. Lackman RL Jamieson AM Griffith JM Geuze H Cresswell P Innate immune recognition triggers secretion of lysosomal enzymes by macrophages Traffic 2007, 8(9):1179-1189. 17555533
74. Young VB Falkow S Schoolnik GK The invasin protein of Yersinia enterocolitica: Internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton J Cell Biol 1992, 116(1):197-207. 2289272 1730744
75. Heit A Gebhardt F Lahl K Neuenhahn M Schmitz F Anderl F Wagner H Sparwasser T Busch DH Kastenmuller K Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity Eur J Immunol 2008, 38(6):1585-1597. 18465771
76. Ritter U Meissner A Ott J Korner H Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-alpha reveals an essential role for TNF J Leukoc Biol 2003, 74(2):216-222. 12885938
77. Trevejo JM Marino MW Philpott N Josien R Richards EC Elkon KB Falck-Pedersen E TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection Proc Natl Acad Sci USA 2001, 98(21):12162-12167. 59785 11593031
78. de Jong EC Smits HH Kapsenberg ML Dendritic cell-mediated T cell polarization Springer Semin Immunopathol 2005, 26(3):289-307. 15609003
79. Imanishi T Hara H Suzuki S Suzuki N Akira S Saito T Cutting edge: TLR2 directly triggers Th1 effector functions J Immunol 2007, 178(11):6715-6719. 17513716
80. Uematsu S Akira S Toll-Like receptors (TLRs) and their ligands Handb Exp Pharmacol 2008:1-20. 18071652